Transparency and public declarations

Patient Organisations

 

Please see below a list of all patient organisations to which Norgine provided financial support and/or significant indirect/non-financial support or engaged for contracted services.  Included in this list are staff fund raising events and donations as well as descriptions of the nature of the support/contracted services which should enable the reader to understand the significance of the support that the patient organisation received, as well as the monetary value of the support.

Norgine’s interactions and support to Patient Organisations

 

 

Medicinal Products Transparency Disclosure

Healthcare Professionals and Organisations

 

In line with the EFPIA Code of Practice and various country Disclosure Codes and legal requirements for transparency, Norgine is disclosing its interactions and relevant transfers of value with healthcare professionals and healthcare organisations. This information includes the support to healthcare organisations in the form of donations and grants, as well as benefits in kind and sponsorship agreements to manage an event.  It also covers the support to healthcare professionals with contributions to cost of events, including registration fees, travel and accommodation, as well as service and consultancy fees and related expenses that may arise. Transfers of value associated with Research and Development are also provided.

Norgine also publishes information from Australia and New Zealand.

Please click on the relevant country icon to view the information related to medicinal products:

If a flag for a particular European country is not displayed below, Norgine has not had interactions or transfers of value data to report for that country over the last 3 years.  Please also note that Norgine works with third parties in some countries and it is the responsibility of the third party to report any qualifying interactions publicly.

 

Interactions with Members of the Public, Patients and Journalists

 

Where the requirement to disclose transfers of value to Members of the Public, Patients and Journalists exist, the information is presented below. If information is not visible for a country, Norgine is not required to disclose such transfers of value as per local Codes of Practice. The information provided will typically include the fees paid and any associated expenses, as well as the type of service that was provided, e.g. speaking at meetings, providing assistance with training, advising on the design of clinical trials, participating in market research with remuneration and/or travel, participating in advisory boards, writing articles or publications

 

United Kingdom

2021 Annual Disclosure for Members of the Public and Patients

 

Collaborative Working with Organisations

 

Norgine is involved in collaborative working projects which either enhances patient care or are for the benefit of patients, or alternatively benefits the Health Services (e.g. NHS in UK) and, as a minimum, maintains patient care. Find out more about these projects by reading the executive summaries below.

 

United Kingdom

Patient Information Forum – Being Induced Survey – Executive Summary